Novavax on Monday released an interim analysis from its ongoing phase 3 trial in the US and Mexico, which showed that its covid-19 vaccine candidate had an efficacy of 90%.

To Subscribe our YouTube channel "NewsX" click on the link below:-

https://www.youtube.com/user/newsxlive/
Watch More Videos: https://www.youtube.com/user/newsxlive
For More information on this News Visit: https://www.newsx.com/


Watch Live on https://www.newsx.com/live-tv/newsx-live-tv-watch-online-india-news/
Latest News Update: https://www.newsx.com/
Entertainment News: https://www.newsxset.com/

Social Media Handles:- Follow us on Facebook, Twitter, Instagram

Instagram: https://www.instagram.com/newsxonline/
Facebook: https://www.facebook.com/Newsxonline
Twitter: https://twitter.com/NewsX